Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing - PubMed (original) (raw)
Comparative Study
doi: 10.1016/j.jmoldx.2013.06.002. Epub 2013 Aug 21.
Affiliations
- PMID: 23973117
- DOI: 10.1016/j.jmoldx.2013.06.002
Free article
Comparative Study
Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing
Volker Endris et al. J Mol Diagn. 2013 Nov.
Free article
Abstract
In the context of personalized oncology, screening for somatic tumor mutations is crucial for prediction of an individual patient's response to therapy. Massive parallel sequencing (MPS) has been suggested for routine diagnostics, but this technology has not been sufficiently evaluated with respect to feasibility, reliability, and cost effectiveness with routine diagnostic formalin-fixed, paraffin-embedded material. We performed ultradeep targeted semiconductor-based MPS (190 amplicons covering hotspot mutations in 46 genes) in a variety of formalin-fixed, paraffin-embedded diagnostic samples of lung adenocarcinoma tissue with known EGFR mutations (n = 28). The samples reflected the typical spectrum of tissue material for diagnostics, including small biopsies and samples with low tumor-cell content. Using MPS, we successfully sequenced all samples, with a mean read depth of 2947 reads per amplicon. High-quality sequence reads were obtained from samples containing ≥10% tumor material. In all but one sample, variant calling identified the same EGFR mutations as were detected by conventional Sanger sequencing. Moreover, we identified 43 additional mutations in 17 genes and detected amplifications in the EGFR and ERBB2 genes. MPS performance was reliable and independent of the type of material, as well as of the fixation and extraction methods, but was influenced by tumor-cell content and the degree of DNA degradation. Using sample multiplexing, focused MPS approached diagnostically acceptable cost rates.
Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.
Similar articles
- Routine Clinical Mutation Profiling of Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Deeb KK, Hohman CM, Risch NF, Metzger DJ, Starostik P. Deeb KK, et al. Arch Pathol Lab Med. 2015 Jul;139(7):913-21. doi: 10.5858/arpa.2014-0095-OA. Arch Pathol Lab Med. 2015. PMID: 26125431 - [Screening for EGFR mutations in lung cancer by a novel real-time PCR with double-loop probe and Sanger DNA sequencing].
Zhang HP, Ruan L, Zheng LM, Bai DY, Zhang HF, Liao YQ, Ding Y. Zhang HP, et al. Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):28-32. doi: 10.3760/cma.j.issn.0253-3766.2013.01.006. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23648296 Chinese. - Utility of different massive parallel sequencing platforms for mutation profiling in clinical samples and identification of pitfalls using FFPE tissue.
Fassunke J, Haller F, Hebele S, Moskalev EA, Penzel R, Pfarr N, Merkelbach-Bruse S, Endris V. Fassunke J, et al. Int J Mol Med. 2015 Nov;36(5):1233-43. doi: 10.3892/ijmm.2015.2339. Epub 2015 Sep 7. Int J Mol Med. 2015. PMID: 26352389 Free PMC article. - A bumpy ride on the diagnostic bench of massive parallel sequencing, the case of the mitochondrial genome.
Vancampenhout K, Caljon B, Spits C, Stouffs K, Jonckheere A, De Meirleir L, Lissens W, Vanlander A, Smet J, De Paepe B, Van Coster R, Seneca S. Vancampenhout K, et al. PLoS One. 2014 Nov 10;9(11):e112950. doi: 10.1371/journal.pone.0112950. eCollection 2014. PLoS One. 2014. PMID: 25383547 Free PMC article. - A new generation of cancer genome diagnostics for routine clinical use: overcoming the roadblocks to personalized cancer medicine.
Heuckmann JM, Thomas RK. Heuckmann JM, et al. Ann Oncol. 2015 Sep;26(9):1830-1837. doi: 10.1093/annonc/mdv184. Epub 2015 Apr 21. Ann Oncol. 2015. PMID: 25899787 Review.
Cited by
- Low microsatellite instability: A distinct instability type in gastric cancer?
Kohlruss M, Chakraborty S, Hapfelmeier A, Jesinghaus M, Slotta-Huspenina J, Novotny A, Sisic L, Gaida MM, Ott K, Weichert W, Pfarr N, Keller G. Kohlruss M, et al. J Cancer Res Clin Oncol. 2023 Dec;149(20):17727-17737. doi: 10.1007/s00432-023-05430-6. Epub 2023 Oct 11. J Cancer Res Clin Oncol. 2023. PMID: 37819581 Free PMC article. - The Performance of an Extended Next Generation Sequencing Panel Using Endobronchial Ultrasound-Guided Fine Needle Aspiration Samples in Non-Squamous Non-Small Cell Lung Cancer: A Pragmatic Study.
Zhang C, Kim RY, McGrath CM, Andronov M, Haas AR, Ma KC, Lanfranco AR, Hutchinson CT, Morrissette JJD, DiBardino DM. Zhang C, et al. Clin Lung Cancer. 2023 Mar;24(2):e105-e112. doi: 10.1016/j.cllc.2022.11.010. Epub 2022 Dec 5. Clin Lung Cancer. 2023. PMID: 36599742 Free PMC article. Clinical Trial. - Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners.
Dermawan JK, Dashti N, Chiang S, Turashvili G, Dickson BC, Ellenson LH, Kirchner M, Stenzinger A, Mechtersheimer G, Agaimy A, Antonescu CR. Dermawan JK, et al. Genes Chromosomes Cancer. 2023 Mar;62(3):152-160. doi: 10.1002/gcc.23109. Epub 2022 Dec 7. Genes Chromosomes Cancer. 2023. PMID: 36445224 Free PMC article. - Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma.
Kazdal D, Rempel E, Oliveira C, Allgäuer M, Harms A, Singer K, Kohlwes E, Ormanns S, Fink L, Kriegsmann J, Leichsenring M, Kriegsmann K, Stögbauer F, Tavernar L, Leichsenring J, Volckmar AL, Longuespée R, Winter H, Eichhorn M, Heußel CP, Herth F, Christopoulos P, Reck M, Muley T, Weichert W, Budczies J, Thomas M, Peters S, Warth A, Schirmacher P, Stenzinger A, Kriegsmann M. Kazdal D, et al. Transl Lung Cancer Res. 2021 Apr;10(4):1666-1678. doi: 10.21037/tlcr-20-1168. Transl Lung Cancer Res. 2021. PMID: 34012783 Free PMC article. - A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma.
Budczies J, Kirchner M, Kluck K, Kazdal D, Glade J, Allgäuer M, Kriegsmann M, Heußel CP, Herth FJ, Winter H, Meister M, Muley T, Fröhling S, Peters S, Seliger B, Schirmacher P, Thomas M, Christopoulos P, Stenzinger A. Budczies J, et al. Oncoimmunology. 2021 Jan 11;10(1):1860586. doi: 10.1080/2162402X.2020.1860586. Oncoimmunology. 2021. PMID: 33520406 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous